Management of diabetes insipidus and adipsia in the child

Natascia Di Iorgi1, Giovanni Morana2, Flavia Napoli1

  • 1Department of Pediatrics, Istituto Giannina Gaslini, University of Genova, Genova, Italy.

Insights

Central diabetes insipidus (CDI) is a challenging diagnosis affecting water balance. This review outlines best practices for diagnosing and treating CDI to prevent neurological damage and other complications.

Area of Science:

  • Endocrinology
  • Neurology
  • Nephrology

Background:

  • Central diabetes insipidus (CDI) is a complex syndrome impacting the hypothalamic-neurohypophyseal system and water homeostasis.
  • A Danish surveillance study reported a CDI prevalence of 23 per 100,000 inhabitants over five years.
  • Differentiating CDI from other polyuric/polydipsic conditions and identifying the underlying etiology present diagnostic challenges.

Purpose of the Study:

  • To review and summarize best practices for the diagnosis and treatment of Central diabetes insipidus.
  • To provide a structured approach for clinicians managing patients with suspected CDI.
  • To emphasize the importance of timely diagnosis for preventing severe health consequences.

Main Methods:

  • Review of current literature and clinical guidelines on CDI diagnosis and management.
  • Synthesis of diagnostic steps, from initial clinical observation to advanced imaging techniques.
  • Discussion of treatment strategies based on etiological diagnosis.

Main Results:

  • A systematic diagnostic pathway is crucial for accurate etiological identification of CDI.
  • Early diagnosis and treatment are essential to prevent central nervous system damage, secondary pituitary deficits, and tumor spread.
  • Multidisciplinary approach involving endocrinologists and neurologists is often required.

Conclusions:

  • Accurate and timely diagnosis of CDI is critical for effective patient management.
  • A stepwise diagnostic approach combining clinical assessment and advanced imaging ensures proper etiological determination.
  • Adherence to best practices in diagnosis and treatment mitigates the risks associated with CDI.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
Regulation of Water Intake01:25

Regulation of Water Intake

Osmolality refers to the number of solute particles per kilogram of solvent in a solution. Plasma osmolality specifically indicates the total number of solute particles per kilogram of water in blood plasma. This value reflects the body's hydration status and is tightly regulated through mechanisms controlling water intake and output. While water consumption is a conscious decision, the body has intrinsic regulatory systems to maintain fluid balance. Dehydration, a state of water deficit...
3.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
868